207 related articles for article (PubMed ID: 27993561)
1. Loss of smooth muscle cell disintegrin and metalloproteinase 17 transiently suppresses angiotensin II-induced hypertension and end-organ damage.
Shen M; Morton J; Davidge ST; Kassiri Z
J Mol Cell Cardiol; 2017 Feb; 103():11-21. PubMed ID: 27993561
[TBL] [Abstract][Full Text] [Related]
2. Evidence That ADAM17 Mediates the Protective Action of CGRP against Angiotensin II-Induced Inflammation in Vascular Smooth Muscle Cells.
Zeng SY; Yang L; Hong CL; Lu HQ; Yan QJ; Chen Y; Qin XP
Mediators Inflamm; 2018; 2018():2109352. PubMed ID: 30046277
[TBL] [Abstract][Full Text] [Related]
3. Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II.
Takayanagi T; Kawai T; Forrester SJ; Obama T; Tsuji T; Fukuda Y; Elliott KJ; Tilley DG; Davisson RL; Park JY; Eguchi S
Hypertension; 2015 Jun; 65(6):1349-55. PubMed ID: 25916723
[TBL] [Abstract][Full Text] [Related]
4. Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) Is Required for Angiotensin II/β-Aminopropionitrile-Induced Abdominal Aortic Aneurysm.
Kawai T; Takayanagi T; Forrester SJ; Preston KJ; Obama T; Tsuji T; Kobayashi T; Boyer MJ; Cooper HA; Kwok HF; Hashimoto T; Scalia R; Rizzo V; Eguchi S
Hypertension; 2017 Nov; 70(5):959-963. PubMed ID: 28947615
[TBL] [Abstract][Full Text] [Related]
5. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
[TBL] [Abstract][Full Text] [Related]
6. Smooth muscle cell-specific Hif-1α deficiency suppresses angiotensin II-induced vascular remodelling in mice.
Imanishi M; Tomita S; Ishizawa K; Kihira Y; Ueno M; Izawa-Ishizawa Y; Ikeda Y; Yamano N; Tsuchiya K; Tamaki T
Cardiovasc Res; 2014 Jun; 102(3):460-8. PubMed ID: 24623277
[TBL] [Abstract][Full Text] [Related]
7. ADAM (a Disintegrin and Metalloproteinase) 15 Deficiency Exacerbates Ang II (Angiotensin II)-Induced Aortic Remodeling Leading to Abdominal Aortic Aneurysm.
Jana S; Chute M; Hu M; Winkelaar G; Owen CA; Oudit GY; Kassiri Z
Arterioscler Thromb Vasc Biol; 2020 Aug; 40(8):1918-1934. PubMed ID: 32522006
[TBL] [Abstract][Full Text] [Related]
8. Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.
Takayanagi T; Forrester SJ; Kawai T; Obama T; Tsuji T; Elliott KJ; Nuti E; Rossello A; Kwok HF; Scalia R; Rizzo V; Eguchi S
Hypertension; 2016 Oct; 68(4):949-955. PubMed ID: 27480833
[TBL] [Abstract][Full Text] [Related]
9. A Disintegrin and Metalloprotease-17 Regulates Pressure Overload-Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin β1.
Fan D; Takawale A; Shen M; Samokhvalov V; Basu R; Patel V; Wang X; Fernandez-Patron C; Seubert JM; Oudit GY; Kassiri Z
Hypertension; 2016 Oct; 68(4):937-48. PubMed ID: 27550917
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
[TBL] [Abstract][Full Text] [Related]
11. A disintegrin and metalloproteinase 17 (ADAM17) mediates epidermal growth factor receptor transactivation by angiotensin II on hepatic stellate cells.
Oikawa H; Maesawa C; Tatemichi Y; Nishinari Y; Nishiya M; Mizugai H; Ikeda A; Oikawa K; Takikawa Y; Masuda T
Life Sci; 2014 Mar; 97(2):137-44. PubMed ID: 24412389
[TBL] [Abstract][Full Text] [Related]
12. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.
Marchesi C; Rehman A; Rautureau Y; Kasal DA; Briet M; Leibowitz A; Simeone SM; Ebrahimian T; Neves MF; Offermanns S; Gonzalez FJ; Paradis P; Schiffrin EL
Cardiovasc Res; 2013 Mar; 97(3):562-70. PubMed ID: 23250918
[TBL] [Abstract][Full Text] [Related]
13. Drebrin regulates angiotensin II-induced aortic remodelling.
Zhang L; Wu JH; Huang TQ; Nepliouev I; Brian L; Zhang Z; Wertman V; Rudemiller NP; McMahon TJ; Shenoy SK; Miller FJ; Crowley SD; Freedman NJ; Stiber JA
Cardiovasc Res; 2018 Nov; 114(13):1806-1815. PubMed ID: 29931051
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression.
Zeng SY; Chen X; Chen SR; Li Q; Wang YH; Zou J; Cao WW; Luo JN; Gao H; Liu PQ
Can J Cardiol; 2013 Oct; 29(10):1310-9. PubMed ID: 23850346
[TBL] [Abstract][Full Text] [Related]
15. ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II.
Ohtsu H; Dempsey PJ; Frank GD; Brailoiu E; Higuchi S; Suzuki H; Nakashima H; Eguchi K; Eguchi S
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):e133-7. PubMed ID: 16840716
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor is critical for angiotensin II-mediated hypertrophy in cerebral arterioles.
Chan SL; Umesalma S; Baumbach GL
Hypertension; 2015 Apr; 65(4):806-12. PubMed ID: 25733240
[TBL] [Abstract][Full Text] [Related]
17. DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy.
Ferguson BS; Wennersten SA; Demos-Davies KM; Rubino M; Robinson EL; Cavasin MA; Stratton MS; Kidger AM; Hu T; Keyse SM; McKnight RA; Lane RH; Nozik ES; Weiser-Evans MCM; McKinsey TA
Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H382-H389. PubMed ID: 34142888
[TBL] [Abstract][Full Text] [Related]
18. Cell-Specific Functions of ADAM17 Regulate the Progression of Thoracic Aortic Aneurysm.
Shen M; Hu M; Fedak PWM; Oudit GY; Kassiri Z
Circ Res; 2018 Jul; 123(3):372-388. PubMed ID: 29930147
[TBL] [Abstract][Full Text] [Related]
19. Deletion of the EGF receptor in vascular smooth muscle cells prevents chronic angiotensin II-induced arterial wall stiffening and media thickening.
Schreier B; Hünerberg M; Mildenberger S; Rabe S; Bethmann D; Wickenhauser C; Gekle M
Acta Physiol (Oxf); 2018 Mar; 222(3):. PubMed ID: 29152859
[TBL] [Abstract][Full Text] [Related]
20. DP1 (Prostaglandin D
Zou F; Li Y; Zhang S; Zhang J
Hypertension; 2022 Jun; 79(6):1203-1215. PubMed ID: 35354317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
